1
|
Benfrid S, Park K, Dellarole M, Voss JE, Tamietti C, Pehau‐Arnaudet G, Raynal B, Brûlé S, England P, Zhang X, Mikhailova A, Hasan M, Ungeheuer M, Petres S, Biering SB, Harris E, Sakuntabhai A, Buchy P, Duong V, Dussart P, Coulibaly F, Bontems F, Rey FA, Flamand M. Dengue virus NS1 protein conveys pro-inflammatory signals by docking onto high-density lipoproteins. EMBO Rep 2022; 23:e53600. [PMID: 35607830 PMCID: PMC10549233 DOI: 10.15252/embr.202153600] [Citation(s) in RCA: 9] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/10/2021] [Revised: 04/24/2022] [Accepted: 04/27/2022] [Indexed: 10/05/2023] Open
Abstract
The dengue virus nonstructural protein 1 (NS1) is a secreted virulence factor that modulates complement, activates immune cells and alters endothelial barriers. The molecular basis of these events remains incompletely understood. Here we describe a functional high affinity complex formed between NS1 and human high-density lipoproteins (HDL). Collapse of the soluble NS1 hexamer upon binding to the lipoprotein particle leads to the anchoring of amphipathic NS1 dimeric subunits into the HDL outer layer. The stable complex can be visualized by electron microscopy as a spherical HDL with rod-shaped NS1 dimers protruding from the surface. We further show that the assembly of NS1-HDL complexes triggers the production of pro-inflammatory cytokines in human primary macrophages while NS1 or HDL alone do not. Finally, we detect NS1 in complex with HDL and low-density lipoprotein (LDL) particles in the plasma of hospitalized dengue patients and observe NS1-apolipoprotein E-positive complexes accumulating overtime. The functional reprogramming of endogenous lipoprotein particles by NS1 as a means to exacerbate systemic inflammation during viral infection provides a new paradigm in dengue pathogenesis.
Collapse
Affiliation(s)
- Souheyla Benfrid
- Unité de Virologie StructuraleInstitut Pasteur and CNRS UMR3569ParisFrance
- Université Paris Descartes SorbonneParis CitéFrance
- Present address:
Laboratoire de Santé AnimaleANSES, INRA, ENVA, UMR 1161Université Paris‐EstMaisons‐AlfortFrance
| | - Kyu‐Ho Park
- Unité de Virologie StructuraleInstitut Pasteur and CNRS UMR3569ParisFrance
- Present address:
Applied Molecular VirologyInstitut Pasteur KoreaSeongnam‐siKorea
| | - Mariano Dellarole
- Unité de Virologie StructuraleInstitut Pasteur and CNRS UMR3569ParisFrance
- Present address:
Virus Biophysics LaboratoryBionanosciences Research Center (CIBION)National Scientific and Technical Research Council (CONICET)Ciudad Autónoma de Buenos AiresArgentina
| | - James E Voss
- Unité de Virologie StructuraleInstitut Pasteur and CNRS UMR3569ParisFrance
- Present address:
Department of Immunology and MicrobiologyThe Scripps Research InstituteLa JollaCAUSA
| | - Carole Tamietti
- Unité de Virologie StructuraleInstitut Pasteur and CNRS UMR3569ParisFrance
| | | | - Bertrand Raynal
- Molecular Biophysics FacilityCNRS UMR 3528Institut PasteurParisFrance
| | - Sébastien Brûlé
- Molecular Biophysics FacilityCNRS UMR 3528Institut PasteurParisFrance
| | - Patrick England
- Molecular Biophysics FacilityCNRS UMR 3528Institut PasteurParisFrance
| | - Xiaokang Zhang
- Unité de Virologie StructuraleInstitut Pasteur and CNRS UMR3569ParisFrance
- Present address:
Guangdong Provincial Key Laboratory of Brain Connectome and Behavior, CAS Key Laboratory of Brain Connectome and Manipulationthe Brain Cognition and Brain Disease Institute (BCBDI)Shenzhen Institutes of Advanced TechnologyChinese Academy of SciencesShenzhen‐Hong Kong Institute of Brain Science‐Shenzhen Fundamental Research InstitutionsShenzhenChina
| | - Anastassia Mikhailova
- HIV Inflammation et PersistanceInstitut PasteurParisFrance
- Present address:
Division of Molecular NeurobiologyDepartment of Medical Biochemistry and BiophysicsKarolinska InstituteStockholmSweden
| | - Milena Hasan
- Cytometry and Biomarkers Unit of Technology and ServiceCB UTechSParisFrance
| | | | - Stéphane Petres
- Production and Purification of Recombinant Proteins FacilityInstitut PasteurParisFrance
| | - Scott B Biering
- Division of Infectious Diseases and VaccinologySchool of Public HealthUniversity of CaliforniaBerkeleyCAUSA
| | - Eva Harris
- Division of Infectious Diseases and VaccinologySchool of Public HealthUniversity of CaliforniaBerkeleyCAUSA
| | | | - Philippe Buchy
- Virology UnitInstitut Pasteur du CambodgeInstitut Pasteur International NetworkPhnom PenhCambodia
- Present address:
GlaxoSmithKline Vaccines R&DSingaporeSingapore
| | - Veasna Duong
- Virology UnitInstitut Pasteur du CambodgeInstitut Pasteur International NetworkPhnom PenhCambodia
| | - Philippe Dussart
- Virology UnitInstitut Pasteur du CambodgeInstitut Pasteur International NetworkPhnom PenhCambodia
| | - Fasséli Coulibaly
- Department of Biochemistry and Molecular BiologyMonash UniversityClaytonVic.Australia
| | - François Bontems
- Unité de Virologie StructuraleInstitut Pasteur and CNRS UMR3569ParisFrance
- Département de Biologie et Chimie StructuralesInstitut de Chimie des Substances Naturelles, CNRS UPR2301Gif‐sur‐YvetteFrance
| | - Félix A Rey
- Unité de Virologie StructuraleInstitut Pasteur and CNRS UMR3569ParisFrance
| | - Marie Flamand
- Unité de Virologie StructuraleInstitut Pasteur and CNRS UMR3569ParisFrance
| |
Collapse
|
2
|
Pérot P, Bielle F, Bigot T, Foulongne V, Bolloré K, Chrétien D, Gil P, Gutiérrez S, L'Ambert G, Mokhtari K, Hellert J, Flamand M, Tamietti C, Coulpier M, Huard de Verneuil A, Temmam S, Couderc T, De Sousa Cunha E, Boluda S, Plu I, Delisle MB, Bonneville F, Brassat D, Fieschi C, Malphettes M, Duyckaerts C, Mathon B, Demeret S, Seilhean D, Eloit M. Identification of Umbre Orthobunyavirus as a Novel Zoonotic Virus Responsible for Lethal Encephalitis in 2 French Patients with Hypogammaglobulinemia. Clin Infect Dis 2021; 72:1701-1708. [PMID: 32516409 DOI: 10.1093/cid/ciaa308] [Citation(s) in RCA: 14] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/22/2020] [Accepted: 03/18/2020] [Indexed: 11/14/2022] Open
Abstract
BACKGROUND Human encephalitis represents a medical challenge from a diagnostic and therapeutic point of view. We investigated the cause of 2 fatal cases of encephalitis of unknown origin in immunocompromised patients. METHODS Untargeted metatranscriptomics was applied on the brain tissue of 2 patients to search for pathogens (viruses, bacteria, fungi, or protozoans) without a prior hypothesis. RESULTS Umbre arbovirus, an orthobunyavirus never previously identified in humans, was found in 2 patients. In situ hybridization and reverse transcriptase-quantitative polymerase chain reaction (RT-qPCR) showed that Umbre virus infected neurons and replicated at high titers. The virus was not detected in cerebrospinal fluid by RT-qPCR. Viral sequences related to Koongol virus, another orthobunyavirus close to Umbre virus, were found in Culex pipiens mosquitoes captured in the south of France where the patients had spent some time before the onset of symptoms, demonstrating the presence of the same clade of arboviruses in Europe and their potential public health impact. A serological survey conducted in the same area did not identify individuals positive for Umbre virus. The absence of seropositivity in the population may not reflect the actual risk of disease transmission in immunocompromised individuals. CONCLUSIONS Umbre arbovirus can cause encephalitis in immunocompromised humans and is present in Europe.
Collapse
Affiliation(s)
- Philippe Pérot
- Pathogen Discovery Laboratory, Institut Pasteur, Paris, France
| | - Franck Bielle
- Département de Neuropathologie Raymond Escourolle, Assistance Publique - Hôpitaux de Paris (AP-HP)-Sorbonne, Groupe Hospitalier Pitié-Salpêtrière, Paris, France.,Sorbonne Université, Brain Institute (Institut du Cerveau et de la Moelle épinière; Institut National de la Santé et de la Recherche Médicale [INSERM], Unité Mixte de Recherche Santé 1127; Centre National de la Recherche Scientifique [CNRS], Unité Mixte de Recherche [UMR] 7225), Paris, France
| | - Thomas Bigot
- Hub de Bioinformatique et Biostatistique - Département Biologie Computationnelle, Institut Pasteur, Unité de Service et de Recherche 3756 CNRS, Paris, France
| | - Vincent Foulongne
- Pathogenesis and Control of Chronic Infections, INSERM, University of Montpellier, Etablissement Français du Sang, Centre Hospitalier Universitaire (CHU) Montpellier, Montpellier, France
| | - Karine Bolloré
- Pathogenesis and Control of Chronic Infections, INSERM, University of Montpellier, Etablissement Français du Sang, Centre Hospitalier Universitaire (CHU) Montpellier, Montpellier, France
| | | | - Patricia Gil
- Centre de Coopération Internationale en Recherche Agronomique Pour le Développement (CIRAD), UMR ASTRE, Montpellier, France.,ASTRE, CIRAD, Institut National de la Recherche Agronomique, University of Montpellier, Montpellier, France
| | - Serafín Gutiérrez
- Centre de Coopération Internationale en Recherche Agronomique Pour le Développement (CIRAD), UMR ASTRE, Montpellier, France.,ASTRE, CIRAD, Institut National de la Recherche Agronomique, University of Montpellier, Montpellier, France
| | - Grégory L'Ambert
- Entente Interdépartementale Pour la Démoustication Méditerranée, Montpellier, France
| | - Karima Mokhtari
- Département de Neuropathologie Raymond Escourolle, Assistance Publique - Hôpitaux de Paris (AP-HP)-Sorbonne, Groupe Hospitalier Pitié-Salpêtrière, Paris, France.,Sorbonne Université, Brain Institute (Institut du Cerveau et de la Moelle épinière; Institut National de la Santé et de la Recherche Médicale [INSERM], Unité Mixte de Recherche Santé 1127; Centre National de la Recherche Scientifique [CNRS], Unité Mixte de Recherche [UMR] 7225), Paris, France
| | - Jan Hellert
- Structural Virology Unit, Institut Pasteur, CNRS UMR 3569, Paris, France
| | - Marie Flamand
- Structural Virology Unit, Institut Pasteur, CNRS UMR 3569, Paris, France
| | - Carole Tamietti
- Structural Virology Unit, Institut Pasteur, CNRS UMR 3569, Paris, France
| | - Muriel Coulpier
- UMR Virologie, Agence Nationale de Sécurité Sanitaire de l'Alimentation, de l'Environnement et du Travail, École Nationale Vétérinaire d'Alfort, Institut National de Recherche Pour l'Agriculture, l'Alimentation et l'Environnement, Université Paris Est, Ecole Nationale Vétérinaire d'Alfort, Maisons-Alfort, France
| | - Anne Huard de Verneuil
- UMR Virologie, Agence Nationale de Sécurité Sanitaire de l'Alimentation, de l'Environnement et du Travail, École Nationale Vétérinaire d'Alfort, Institut National de Recherche Pour l'Agriculture, l'Alimentation et l'Environnement, Université Paris Est, Ecole Nationale Vétérinaire d'Alfort, Maisons-Alfort, France
| | - Sarah Temmam
- Pathogen Discovery Laboratory, Institut Pasteur, Paris, France
| | - Thérèse Couderc
- Biology of Infection Unit, Institut Pasteur, INSERM U1117, Paris, France
| | - Edouard De Sousa Cunha
- Département de Neuropathologie Raymond Escourolle, Assistance Publique - Hôpitaux de Paris (AP-HP)-Sorbonne, Groupe Hospitalier Pitié-Salpêtrière, Paris, France
| | - Susana Boluda
- Département de Neuropathologie Raymond Escourolle, Assistance Publique - Hôpitaux de Paris (AP-HP)-Sorbonne, Groupe Hospitalier Pitié-Salpêtrière, Paris, France.,Sorbonne Université, Brain Institute (Institut du Cerveau et de la Moelle épinière; Institut National de la Santé et de la Recherche Médicale [INSERM], Unité Mixte de Recherche Santé 1127; Centre National de la Recherche Scientifique [CNRS], Unité Mixte de Recherche [UMR] 7225), Paris, France.,Centre National de Référence des Agents Transmissibles Non Conventionnels (Reference Center for Nonconventional Transmissible Agents), Laboratory and Neuropathology Network for the Surveillance of Creutzfeldt-Jakob Disease, Santé Publique France, AP-HP, Paris, France
| | - Isabelle Plu
- Département de Neuropathologie Raymond Escourolle, Assistance Publique - Hôpitaux de Paris (AP-HP)-Sorbonne, Groupe Hospitalier Pitié-Salpêtrière, Paris, France.,Sorbonne Université, Brain Institute (Institut du Cerveau et de la Moelle épinière; Institut National de la Santé et de la Recherche Médicale [INSERM], Unité Mixte de Recherche Santé 1127; Centre National de la Recherche Scientifique [CNRS], Unité Mixte de Recherche [UMR] 7225), Paris, France.,Centre National de Référence des Agents Transmissibles Non Conventionnels (Reference Center for Nonconventional Transmissible Agents), Laboratory and Neuropathology Network for the Surveillance of Creutzfeldt-Jakob Disease, Santé Publique France, AP-HP, Paris, France
| | - Marie Bernadette Delisle
- Laboratoire de Neuropathologie, Laboratoire Universitaire d'Anatomie et Cytologie Pathologiques, CHU de Toulouse, Université Toulouse III-Paul Sabatier, Toulouse, France
| | - Fabrice Bonneville
- Department of Neuroradiology, CHU de Toulouse and UMR 1214 Toulouse NeuroImaging Center, Université de Toulouse, INSERM, Toulouse, France
| | - David Brassat
- Centre de Ressources et de Compétences Sclérose en Plaques, Pole des Neurosciences CHU Toulouse and UMR 1043, Université de Toulouse III, Toulouse, France
| | - Claire Fieschi
- Service d'Immunologie Clinique, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Université de Paris, Paris, France
| | - Marion Malphettes
- Service d'Immunologie Clinique, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Université de Paris, Paris, France
| | - Charles Duyckaerts
- Département de Neuropathologie Raymond Escourolle, Assistance Publique - Hôpitaux de Paris (AP-HP)-Sorbonne, Groupe Hospitalier Pitié-Salpêtrière, Paris, France.,Sorbonne Université, Brain Institute (Institut du Cerveau et de la Moelle épinière; Institut National de la Santé et de la Recherche Médicale [INSERM], Unité Mixte de Recherche Santé 1127; Centre National de la Recherche Scientifique [CNRS], Unité Mixte de Recherche [UMR] 7225), Paris, France
| | - Bertrand Mathon
- Sorbonne Université, Brain Institute (Institut du Cerveau et de la Moelle épinière; Institut National de la Santé et de la Recherche Médicale [INSERM], Unité Mixte de Recherche Santé 1127; Centre National de la Recherche Scientifique [CNRS], Unité Mixte de Recherche [UMR] 7225), Paris, France.,AP-HP, Hôpitaux Universitaires Pitié-Salpêtrière Charles-Foix, Department of Neurosurgery, Paris, France
| | - Sophie Demeret
- Department of Neurology, Neuro ICU, Groupe Hospitalier Pitié-Salpêtrière, AP-HP, Paris, France
| | - Danielle Seilhean
- Département de Neuropathologie Raymond Escourolle, Assistance Publique - Hôpitaux de Paris (AP-HP)-Sorbonne, Groupe Hospitalier Pitié-Salpêtrière, Paris, France.,Sorbonne Université, Brain Institute (Institut du Cerveau et de la Moelle épinière; Institut National de la Santé et de la Recherche Médicale [INSERM], Unité Mixte de Recherche Santé 1127; Centre National de la Recherche Scientifique [CNRS], Unité Mixte de Recherche [UMR] 7225), Paris, France.,Centre National de Référence des Agents Transmissibles Non Conventionnels (Reference Center for Nonconventional Transmissible Agents), Laboratory and Neuropathology Network for the Surveillance of Creutzfeldt-Jakob Disease, Santé Publique France, AP-HP, Paris, France
| | - Marc Eloit
- Pathogen Discovery Laboratory, Institut Pasteur, Paris, France.,Ecole Nationale Vétérinaire d'Alfort, Maisons-Alfort, France
| |
Collapse
|
3
|
Léger P, Nachman E, Richter K, Tamietti C, Koch J, Burk R, Kummer S, Xin Q, Stanifer M, Bouloy M, Boulant S, Kräusslich HG, Montagutelli X, Flamand M, Nussbaum-Krammer C, Lozach PY. NSs amyloid formation is associated with the virulence of Rift Valley fever virus in mice. Nat Commun 2020; 11:3281. [PMID: 32612175 PMCID: PMC7329897 DOI: 10.1038/s41467-020-17101-y] [Citation(s) in RCA: 29] [Impact Index Per Article: 7.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/17/2019] [Accepted: 06/13/2020] [Indexed: 12/22/2022] Open
Abstract
Amyloid fibrils result from the aggregation of host cell-encoded proteins, many giving rise to specific human illnesses such as Alzheimer’s disease. Here we show that the major virulence factor of Rift Valley fever virus, the protein NSs, forms filamentous structures in the brain of mice and affects mortality. NSs assembles into nuclear and cytosolic disulfide bond-dependent fibrillary aggregates in infected cells. NSs structural arrangements exhibit characteristics typical for amyloids, such as an ultrastructure of 12 nm-width fibrils, a strong detergent resistance, and interactions with the amyloid-binding dye Thioflavin-S. The assembly dynamics of viral amyloid-like fibrils can be visualized in real-time. They form spontaneously and grow in an amyloid fashion within 5 hours. Together, our results demonstrate that viruses can encode amyloid-like fibril-forming proteins and have strong implications for future research on amyloid aggregation and toxicity in general. Rift Valley fever virus (RVFV) can cause severe diseases in humans, including encephalitis. Here the authors show that NSs, the major virulence factor of RVFV, is an amyloidogenic protein forming fibrils in infected mouse brains and causing increased mortality in mice.
Collapse
Affiliation(s)
- Psylvia Léger
- CellNetworks-Cluster of Excellence and Virology, University Hospital Heidelberg, 69120, Heidelberg, Germany.,Center for Integrative Infectious Diseases Research (CIID), Virology, University Hospital Heidelberg, 69120, Heidelberg, Germany
| | - Eliana Nachman
- Center for Molecular Biology of Heidelberg University (ZMBH) and German Cancer Research Center (DKFZ), DKFZ-ZMBH Alliance, 69120, Heidelberg, Germany
| | | | | | - Jana Koch
- CellNetworks-Cluster of Excellence and Virology, University Hospital Heidelberg, 69120, Heidelberg, Germany.,Center for Integrative Infectious Diseases Research (CIID), Virology, University Hospital Heidelberg, 69120, Heidelberg, Germany
| | - Robin Burk
- Center for Integrative Infectious Diseases Research (CIID), Virology, University Hospital Heidelberg, 69120, Heidelberg, Germany
| | - Susann Kummer
- Center for Integrative Infectious Diseases Research (CIID), Virology, University Hospital Heidelberg, 69120, Heidelberg, Germany
| | - Qilin Xin
- University Lyon, INRAE, EPHE, IVPC, 69007, Lyon, France
| | - Megan Stanifer
- Center for Integrative Infectious Diseases Research (CIID), Virology, University Hospital Heidelberg, 69120, Heidelberg, Germany.,DKFZ, 69120, Heidelberg, Germany
| | - Michèle Bouloy
- Unité de Génétique Moléculaire des Bunyavirus, Institut Pasteur, 75015, Paris, France
| | - Steeve Boulant
- Center for Integrative Infectious Diseases Research (CIID), Virology, University Hospital Heidelberg, 69120, Heidelberg, Germany.,DKFZ, 69120, Heidelberg, Germany
| | - Hans-Georg Kräusslich
- Center for Integrative Infectious Diseases Research (CIID), Virology, University Hospital Heidelberg, 69120, Heidelberg, Germany
| | | | - Marie Flamand
- Structural Virology, Institut Pasteur, 75015, Paris, France
| | - Carmen Nussbaum-Krammer
- Center for Molecular Biology of Heidelberg University (ZMBH) and German Cancer Research Center (DKFZ), DKFZ-ZMBH Alliance, 69120, Heidelberg, Germany
| | - Pierre-Yves Lozach
- CellNetworks-Cluster of Excellence and Virology, University Hospital Heidelberg, 69120, Heidelberg, Germany. .,Center for Integrative Infectious Diseases Research (CIID), Virology, University Hospital Heidelberg, 69120, Heidelberg, Germany. .,University Lyon, INRAE, EPHE, IVPC, 69007, Lyon, France.
| |
Collapse
|
4
|
Mounce BC, Cesaro T, Moratorio G, Hooikaas PJ, Yakovleva A, Werneke SW, Smith EC, Poirier EZ, Simon-Loriere E, Prot M, Tamietti C, Vitry S, Volle R, Khou C, Frenkiel MP, Sakuntabhai A, Delpeyroux F, Pardigon N, Flamand M, Barba-Spaeth G, Lafon M, Denison MR, Albert ML, Vignuzzi M. Inhibition of Polyamine Biosynthesis Is a Broad-Spectrum Strategy against RNA Viruses. J Virol 2016; 90:9683-9692. [PMID: 27535047 PMCID: PMC5068521 DOI: 10.1128/jvi.01347-16] [Citation(s) in RCA: 54] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2016] [Accepted: 08/06/2016] [Indexed: 11/20/2022] Open
Abstract
RNA viruses present an extraordinary threat to human health, given their sudden and unpredictable appearance, the potential for rapid spread among the human population, and their ability to evolve resistance to antiviral therapies. The recent emergence of chikungunya virus, Zika virus, and Ebola virus highlights the struggles to contain outbreaks. A significant hurdle is the availability of antivirals to treat the infected or protect at-risk populations. While several compounds show promise in vitro and in vivo, these outbreaks underscore the need to accelerate drug discovery. The replication of several viruses has been described to rely on host polyamines, small and abundant positively charged molecules found in the cell. Here, we describe the antiviral effects of two molecules that alter polyamine levels: difluoromethylornithine (DFMO; also called eflornithine), which is a suicide inhibitor of ornithine decarboxylase 1 (ODC1), and diethylnorspermine (DENSpm), an activator of spermidine/spermine N1-acetyltransferase (SAT1). We show that reducing polyamine levels has a negative effect on diverse RNA viruses, including several viruses involved in recent outbreaks, in vitro and in vivo These findings highlight the importance of the polyamine biosynthetic pathway to viral replication, as well as its potential as a target in the development of further antivirals or currently available molecules, such as DFMO. IMPORTANCE RNA viruses present a significant hazard to human health, and combatting these viruses requires the exploration of new avenues for targeting viral replication. Polyamines, small positively charged molecules within the cell, have been demonstrated to facilitate infection for a few different viruses. Our study demonstrates that diverse RNA viruses rely on the polyamine pathway for replication and highlights polyamine biosynthesis as a promising drug target.
Collapse
Affiliation(s)
- Bryan C Mounce
- Viral Populations and Pathogenesis Unit, Institut Pasteur, Paris, France
| | - Teresa Cesaro
- Viral Populations and Pathogenesis Unit, Institut Pasteur, Paris, France
| | - Gonzalo Moratorio
- Viral Populations and Pathogenesis Unit, Institut Pasteur, Paris, France
| | - Peter Jan Hooikaas
- Viral Populations and Pathogenesis Unit, Institut Pasteur, Paris, France
| | - Anna Yakovleva
- Viral Populations and Pathogenesis Unit, Institut Pasteur, Paris, France
| | - Scott W Werneke
- Laboratory of Dendritic Cell Biology, Institut Pasteur, Paris, France Institut National de la Santé et de la Recherche Médicale, U818, Paris, France
| | - Everett Clinton Smith
- Department of Pediatrics, the Elizabeth B. Lamb Center for Pediatric Research, Vanderbilt University Medical Center, Nashville, Tennessee, USA
| | - Enzo Z Poirier
- Viral Populations and Pathogenesis Unit, Institut Pasteur, Paris, France University Paris Diderot, Sorbonne Paris Cite, Cellule Pasteur, Paris, France
| | - Etienne Simon-Loriere
- Unité de Génétique Fonctionnelle des Maladies Infectieuses, Institut Pasteur, Paris, France
| | - Matthieu Prot
- Unité de Génétique Fonctionnelle des Maladies Infectieuses, Institut Pasteur, Paris, France
| | - Carole Tamietti
- Unité de Virologie Structurale, Institut Pasteur, Paris, France
| | - Sandrine Vitry
- Unité de NeuroImmunologie Virale, Institut Pasteur, Paris, France
| | - Romain Volle
- Unité de Biologie des Virus Entériques, Institut Pasteur, Paris, France INSERM, Unité 994, Paris, France
| | - Cécile Khou
- Unité de Recherche et d'Expertise Environnement et Risques Infectieux, Institut Pasteur, Paris, France
| | - Marie-Pascale Frenkiel
- Unité de Recherche et d'Expertise Environnement et Risques Infectieux, Institut Pasteur, Paris, France
| | - Anavaj Sakuntabhai
- Unité de Génétique Fonctionnelle des Maladies Infectieuses, Institut Pasteur, Paris, France
| | - Francis Delpeyroux
- Unité de Biologie des Virus Entériques, Institut Pasteur, Paris, France INSERM, Unité 994, Paris, France
| | - Nathalie Pardigon
- Unité de Recherche et d'Expertise Environnement et Risques Infectieux, Institut Pasteur, Paris, France
| | - Marie Flamand
- Unité de Virologie Structurale, Institut Pasteur, Paris, France
| | | | - Monique Lafon
- Unité de NeuroImmunologie Virale, Institut Pasteur, Paris, France
| | - Mark R Denison
- Department of Pediatrics, the Elizabeth B. Lamb Center for Pediatric Research, Vanderbilt University Medical Center, Nashville, Tennessee, USA Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA
| | - Matthew L Albert
- Laboratory of Dendritic Cell Biology, Institut Pasteur, Paris, France Institut National de la Santé et de la Recherche Médicale, U818, Paris, France
| | - Marco Vignuzzi
- Viral Populations and Pathogenesis Unit, Institut Pasteur, Paris, France
| |
Collapse
|
5
|
Kreher F, Tamietti C, Gommet C, Guillemot L, Ermonval M, Failloux AB, Panthier JJ, Bouloy M, Flamand M. The Rift Valley fever accessory proteins NSm and P78/NSm-GN are distinct determinants of virus propagation in vertebrate and invertebrate hosts. Emerg Microbes Infect 2014; 3:e71. [PMID: 26038497 PMCID: PMC4217093 DOI: 10.1038/emi.2014.71] [Citation(s) in RCA: 50] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/09/2014] [Revised: 08/05/2014] [Accepted: 08/10/2014] [Indexed: 02/05/2023]
Abstract
Rift Valley fever virus (RVFV) is an enzootic virus circulating in Africa that is transmitted to its vertebrate host by a mosquito vector and causes severe clinical manifestations in humans and ruminants. RVFV has a tripartite genome of negative or ambisense polarity. The M segment contains five in-frame AUG codons that are alternatively used for the synthesis of two major structural glycoproteins, GN and GC, and at least two accessory proteins, NSm, a 14-kDa cytosolic protein, and P78/NSm-GN, a 78-kDa glycoprotein. To determine the relative contribution of P78 and NSm to RVFV infectivity, AUG codons were knocked out to generate mutant viruses expressing various sets of the M-encoded proteins. We found that, in the absence of the second AUG codon used to express NSm, a 13-kDa protein corresponding to an N-terminally truncated form of NSm, named NSm′, was synthesized from AUG 3. None of the individual accessory proteins had any significant impact on RVFV virulence in mice. However, a mutant virus lacking both NSm and NSm′ was strongly attenuated in mice and grew to reduced titers in murine macrophages, a major target cell type of RVFV. In contrast, P78 was not associated with reduced viral virulence in mice, yet it appeared as a major determinant of virus dissemination in mosquitoes. This study demonstrates how related accessory proteins differentially contribute to RVFV propagation in mammalian and arthropod hosts.
Collapse
Affiliation(s)
- Felix Kreher
- Molecular Genetics of Bunyaviruses, Institut Pasteur , F-75015 Paris, France ; Structural Virology, Institut Pasteur , F-75015 Paris, France ; Univ Paris Diderot, Sorbonne Paris Cité , F-75205 Paris, France
| | - Carole Tamietti
- Molecular Genetics of Bunyaviruses, Institut Pasteur , F-75015 Paris, France ; Structural Virology, Institut Pasteur , F-75015 Paris, France
| | - Céline Gommet
- Mouse Functional Genetics, Institut Pasteur , F-75015 Paris, France ; CNRS URA 2578, Institut Pasteur , F-75015 Paris, France ; Central Animal Facilities, Institut Pasteur , F-75015 Paris, France
| | - Laurent Guillemot
- Mouse Functional Genetics, Institut Pasteur , F-75015 Paris, France ; CNRS URA 2578, Institut Pasteur , F-75015 Paris, France
| | - Myriam Ermonval
- Molecular Genetics of Bunyaviruses, Institut Pasteur , F-75015 Paris, France
| | | | - Jean-Jacques Panthier
- Mouse Functional Genetics, Institut Pasteur , F-75015 Paris, France ; CNRS URA 2578, Institut Pasteur , F-75015 Paris, France
| | - Michèle Bouloy
- Molecular Genetics of Bunyaviruses, Institut Pasteur , F-75015 Paris, France
| | - Marie Flamand
- Molecular Genetics of Bunyaviruses, Institut Pasteur , F-75015 Paris, France ; Structural Virology, Institut Pasteur , F-75015 Paris, France
| |
Collapse
|